Discover six hemophilia companies developing new treatments for the genetic bleeding disorder, from gene therapies to RNAi therapies.

Q3 2025 Earnings Conference Call April 29, 2025 10:00 AM ETCompany ParticipantsKevin Kim - VP, IRKevin Hourican - Chairman ...

Canada's three major political parties finished Election Day with class, as they welcomed a united future for Canadians ...

Canada's three major political parties finished Election Day with class, as they welcomed a united future for Canadians ...

This study highlights the promising potential of LC–MS as a powerful tool for mAb quality control within the context of upstream processing.